Spriggs Meg J, Murphy-Beiner Ashleigh, Murphy Roberta, Bornemann Julia, Thurgur Hannah, Schlag Anne K
Division of Psychiatry, Department of Brain Sciences, Centre for Psychedelic Research, Imperial College London, London, United Kingdom.
Drug Science, London, United Kingdom.
Front Psychol. 2023 May 11;14:1119115. doi: 10.3389/fpsyg.2023.1119115. eCollection 2023.
The field of psychedelic assisted therapy (PAT) is growing at an unprecedented pace. The immense pressures this places on those working in this burgeoning field have already begun to raise important questions about risk and responsibility. It is imperative that the development of an ethical and equitable infrastructure for psychedelic care is prioritized to support this rapid expansion of PAT in research and clinical settings. Here we present Access, Reciprocity and Conduct (ARC); a framework for a culturally informed ethical infrastructure for ARC in psychedelic therapies. These three parallel yet interdependent pillars of ARC provide the bedrock for a sustainable psychedelic infrastructure which prioritized equal access to PAT for those in need of mental health treatment (Access), promotes the safety of those delivering and receiving PAT in clinical contexts (Conduct), and respects the traditional and spiritual uses of psychedelic medicines which often precede their clinical use (Reciprocity). In the development of ARC, we are taking a novel dual-phase co-design approach. The first phase involves co-development of an ethics statement for each arm with stakeholders from research, industry, therapy, community, and indigenous settings. A second phase will further disseminate the statements for collaborative review to a wider audience from these different stakeholder communities within the psychedelic therapy field to invite feedback and further refinement. By presenting ARC at this early stage, we hope to draw upon the collective wisdom of the wider psychedelic community and inspire the open dialogue and collaboration upon which the process of co-design depends. We aim to offer a framework through which psychedelic researchers, therapists and other stakeholders, may begin tackling the complex ethical questions arising within their own organizations and individual practice of PAT.
迷幻辅助疗法(PAT)领域正以前所未有的速度发展。这给这个新兴领域的从业者带来的巨大压力,已经开始引发有关风险和责任的重要问题。当务之急是优先发展一个符合伦理道德且公平的迷幻治疗基础设施,以支持PAT在研究和临床环境中的快速扩张。在此,我们提出“准入、互惠与行为规范”(ARC);这是一个为迷幻疗法中符合文化背景的伦理基础设施提供的框架。ARC的这三个平行且相互依存的支柱,为可持续的迷幻基础设施奠定了基础,该基础设施优先考虑让有心理健康治疗需求的人平等获得PAT(准入),促进在临床环境中提供和接受PAT的人员的安全(行为规范),并尊重迷幻药物在临床使用之前的传统和精神用途(互惠)。在ARC的开发过程中,我们采用了一种全新的双阶段协同设计方法。第一阶段涉及与来自研究、行业、治疗、社区和本土环境的利益相关者共同制定每个方面的伦理声明。第二阶段将进一步向迷幻疗法领域内这些不同利益相关者群体的更广泛受众传播这些声明以供协作审查,以征求反馈意见并进一步完善。通过在这个早期阶段介绍ARC,我们希望汲取更广泛的迷幻社区的集体智慧,激发协同设计过程所依赖的开放对话与合作。我们的目标是提供一个框架,通过它迷幻研究人员、治疗师和其他利益相关者可以开始解决在他们自己组织和个人PAT实践中出现的复杂伦理问题。